Anand Swaminath

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.8K citations

Open-label Trial, Radiation Therapy, Medicine +7

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Stereotactic body radiotherapy for colorectal liver metastases

Daniel T. Chang, Anand Swaminath, Margaret M. Kozak et al. · Cancer · 2011 · 296 citations · Full text

The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy

Arjun Sahgal, David Roberge, Devin Schellenberg et al. · Clinical Oncology · 2012 · 260 citations

Canadian Association, Radiation Therapy, Radiation Oncology Scope +9

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

David A. Palma, Robert Olson, Stephen Harrow et al. · BMC Cancer · 2019 · 250 citations · Full text